Speaking Genomics in Clinical Care Symposium

Tuesday, April 2, 2024, 7:30 AM - 5:00 PM, Annenberg - Stern Auditorium, New York, NY


This one-day symposium, led by the Mount Sinai Institute for Genomic Health, aims to bring together leading experts and scholars in the field of genomic medicine to share knowledge, foster collaboration, and inspire our community and is designed to educate and empower Mount Sinai physicians and other medical professionals to gain knowledge of how genomics will increasingly influence decisions around patient care. It is geared toward a broad clinical audience of general practitioners and non-genetics specialists.

1. Describe different types of genomic tests available and how to use them appropriately in clinical care.
2. Interpret genomic test results and use them to inform the prevention, diagnosis, and management of common conditions.
3. Explain to patients the role of genomic screening in preventive health, and guide patients to make decisions regarding genomic tests.

Non-CME credit option: If you are unable to attend in person but would like to learn about a streaming option, please e-mail [email protected] (Note: CME credit is not available for virtual attendance; CME site registration is not required for this option).

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Tuesday, April 2, 2024